UNSPSC 51284100: Third generation cephalosporins

This classification denotes the third variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, hence the term CEPHALOSPORIN.

UNSPSC 51284100 Third generation cephalosporins is a Class code, but the recent state and local opportunities posted under it do not align with pharmaceutical active ingredients—the code's nominal scope. Instead, the solicitations reflect a broader mix of emergency medical supplies, naloxone products, direct-to-manufacturer pharmacy procurement programs, and generic pharmaceutical distribution through cooperative purchasing vehicles. The mismatch between code classification and actual procurement activity suggests either miscoding in the state and local procurement systems or a significant divergence between the taxonomy's intended use and how issuing bodies are tagging opportunities in practice. State and local governments are clearly buying finished medical products, OTC supplies, and pharmacy benefit management services through this code, but the recent activity does not center on third-generation cephalosporin antibiotics specifically.

Activity appears across Florida counties, Texas state agencies, and multi-state cooperative purchasing alliances. Seminole County, Florida released an IFB on June 30, 2026 (due July 26, 2023, per the source) for naloxone and drug deactivation systems—1,900 units annually—intended for community health support through quarterly delivery to the Seminole County Community Health Building. The Texas Health and Human Services Commission issued an RFI on April 3, 2026 to explore direct-to-manufacturer prescription fulfillment models for self-insured employers and state agencies. The City of Tampa Purchasing Department posted an ITB on March 25, 2026 (due March 13, 2026) for medical and first aid supplies for the Tampa Fire Department Rescue Division, covering 169 line items with an estimated contract value of $700,000, sheltered exclusively for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed through three authorized wholesalers—AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson—with awards effective July 1, 2026 and a two-year term. No clear geographic concentration emerges; activity spans Florida, Texas, and multi-state cooperative purchasing mechanisms, with no standout repeat buyers visible in the recent opportunities block.